US FDA Advisory Committee Reboot (Part II): The Right Balance For Conflicts Of Interest

 
• By Kate Rawson

After back-and-forth tinkering with CoI restrictions, CDER is still finding it challenging to seat the right experts. Maybe more realistic guidelines are needed.

wooden balance beam
FDA WILL NEED TO BE NIMBLE TO BALANCE THE CONFLICTING DEMANDS ON ITS ADVISORY COMMITTEES • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers